High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Buc, Emmanuel ^a,b,c   Dubois, Damien ^a,b,c   Sauvanet, Pierre ^a,b,c   Raisch, Jennifer ^a,b   Delmas, Julien ^a,b,c   Darfeuille Michaud, Arlette ^a,b,c   Pezet, Denis ^a,b,c   Bonnet, Richard ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CEMAGREF   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYCLOMODULIN; UNCLASSIFIED DRUG;

ADHERENT CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL CULTURE; CELL CYCLE; COLON CANCER; COLON MUCOSA; COMET ASSAY; DIVERTICULOSIS; DNA DAMAGE; ESCHERICHIA COLI; GENE FUNCTION; GENOTOXICITY; HOST CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTESTINE EPITHELIUM; MAJOR CLINICAL STUDY; NONHUMAN; PHYLOGENY; PREVALENCE; QUALITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL ADHESION; BACTERIAL TOXINS; COLONIC NEOPLASMS; ESCHERICHIA COLI; HUMANS; INTESTINAL MUCOSA; MIDDLE AGED; MUTAGENS; PHENOTYPE; PREVALENCE;

EID: 84874007506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056964     Document Type: Article

References (75)

1. Karsa LV, Lignini TA, Patnick J, Lambert R, Sauvaget C, (2010) The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol 24: 381-396.
2. Kwak EL, Chung DC, (2007) Hereditary colorectal cancer syndromes: an overview. Clin Colorectal Cancer 6: 340-344.
3. Half E, Bercovich D, Rozen P, (2009) Familial adenomatous polyposis. Orphanet Journal of Rare Diseases 4: 1-23.
4. Collins D, Hogan AM, Winter DC, (2011) Microbial and viral pathogens in colorectal cancer. Lancet Oncol 12: 504-512.
5. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, et al. (1998) Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115: 281-286.
6. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, et al. (2004) Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 80-93.
7. Bronowski C, Smith SL, Yokota K, Corkill JE, Martin HM, et al. (2008) A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. Microbiology 154: 571-583 doi:10.1099/mic.0.2007/013086-0.
8. Nougayrede JP, Taieb F, De Rycke J, Oswald E, (2005) Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 13: 103-110.
9. Wu S, Morin PJ, Maouyo D, Sears CL, (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124: 392-400.
10. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022.
11. Leser TD, Molbak L, (2009) Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ Microbiol 11: 2194-2206.
12. Chassaing B, Darfeuille-Michaud A, (2011) The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1720-1728.
13. Croxen MA, Finlay BB, (2009) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8: 26-38.
14. Kaper JB, Nataro JP, Mobley HL, (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140 doi:10.1038/nrmicro818.
15. Clermont O, Bonacorsi S, Bingen E, (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
16. Herzer PJ, Inouye S, Inouye M, Whittam TS, (1990) Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 172: 6175-6181.
17. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, et al. (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67: 546-553.
18. Escobar-Páramo P, Sabbagh A, Darlu P, Pradillon O, Vaury C, et al. (2004) Decreasing the effects of horizontal gene transfer on bacterial phylogeny?: the Escherichia coli case study. Molecular Phylogenetics and Evolution 30: 243-250 doi:10.1016/S1055-7903(03)00181-7.
19. Escobar-Páramo P, Clermont O, Blanc-Potard A-B, Bui H, Le Bouguénec C, et al. (2004) A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Molecular biology and evolution 21: 1085-1094 doi:10.1093/molbev/msh118.
20. Taieb F, Nougayrede JP, Watrin C, Samba-Louaka A, Oswald E, (2006) Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell Microbiol 8: 1910-1921.
21. Jubelin G, Taieb F, Duda DM, Hsu Y, Samba-Louaka A, et al. (2010) Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog 6: e1001128.
22. Nougayrède J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, et al. (2006) Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313: 848-851 doi:10.1126/science.1127059.
23. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, et al. (2010) Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 107: 11537-11542.
24. De Rycke J, Oswald E, (2001) Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS microbiology letters 203: 141-148.
25. Ge Z, Rogers AB, Feng Y, Lee A, Xu S, et al. (2007) Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 9: 2070-2080.
26. Ge Z, Schauer DB, Fox JG, (2008) In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol 10: 1599-1607.
27. Versalovic J, Koeuth T, Lupski JR, (1991) Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19: 6823-6831.
28. Wang G, Whittam TS, Berg CM, Berg DE, (1993) RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains. Nucleic Acids Res 21: 5930-5933.
29. Bidet P, Metais A, Mahjoub-Messai F, Durand L, Dehem M, et al. (2007) Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains. Appl Environ Microbiol 73: 2373-2377.
30. Dubois D, Delmas J, Cady A, Robin F, Sivignon A, et al. (2010) Cyclomodulins in urosepsis strains of Escherichia coli. J Clin Microbiol 48: 2122-2129.
31. Peres SY, Marches O, Daigle F, Nougayrede JP, Herault F, et al. (1997) A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 24: 1095-1107.
32. Boudeau J, Barnich N, Darfeuille-Michaud A, (2001) Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 39: 1272-1284.
33. Sert V, Cans C, Tasca C, Bret-Bennis L, Oswald E, et al. (1999) The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 18: 6296-6304 doi:10.1038/sj.onc.1203007.
34. Orden JA, Dominguez-Bernal G, Martinez-Pulgarin S, Blanco M, Blanco JE, et al. (2007) Necrotoxigenic Escherichia coli from sheep and goats produce a new type of cytotoxic necrotizing factor (CNF3) associated with the eae and ehxA genes. Int Microbiol 10: 47-55.
35. Johnson JR, Johnston B, Kuskowski MA, Nougayrede JP, Oswald E, (2008) Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol 46: 3906-3911.
36. De Rycke J, Milon A, Oswald E, (1999) Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. Vet Res 30: 221-233.
37. Johnson TJ, DebRoy C, Belton S, Williams ML, Lawrence M, et al. (2010) Pyrosequencing of the Vir plasmid of necrotoxigenic Escherichia coli. Vet Microbiol 144: 100-109.
38. Pandey M, Khan A, Das SC, Sarkar B, Kahali S, et al. (2003) Association of cytolethal distending toxin locus cdtB with enteropathogenic Escherichia coli isolated from patients with acute diarrhea in Calcutta, India. J Clin Microbiol 41: 5277-5281.
39. Bielaszewska M, Fell M, Greune L, Prager R, Fruth A, et al. (2004) Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 72: 1812-1816.
40. Orth D, Grif K, Khan AB, Naim A, Dierich MP, et al. (2007) The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis 59: 235-242.
41. Loukiadis E, Nobe R, Herold S, Tramuta C, Ogura Y, et al. (2008) Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J Bacteriol 190: 275-285.
42. Marchès O, Ledger TN, Boury M, Ohara M, Tu X, et al. (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Molecular Microbiology 50: 1553-1567 doi:10.1046/j.1365-2958.2003.03821.x.
43. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, et al. (2004) Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 80-93 doi:10.1053/j.gastro.2004.03.054.
44. Kotlowski R, Bernstein CN, Sepehri S, Krause DO, (2007) High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56: 669-675.
45. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, et al. (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 117: 1566-1574.
46. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, et al. (2009) Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 206: 2179-2189.
47. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, et al. (2000) Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 156: 595-605.
48. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, et al. (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21: 3638-3646.
49. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, et al. (2012) Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science 338: 120-123.
50. Janelle AC, Tomkovich SE, Muehlbauer M, Ting-Jia F, Dogan B, et al. (2012) The E. coli Genotoxic Island Pks Promotes Colorectal Cancer (CRC) Without Impacting Intestinal Inflammation. Gastroenterology 142: S-639.
51. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, et al. (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350: 239-248.
52. Nagamine CM, Sohn JJ, Rickman BH, Rogers AB, Fox JG, et al. (2008) Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse. Infect Immun 76: 2758-2766.
53. Nagamine CM, Rogers AB, Fox JG, Schauer DB, (2008) Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer 122: 832-838.
54. Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, et al. (2010) Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59: 88-97.
55. Lemonnier M, Landraud L, Lemichez E, (2007) Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 31: 515-534.
56. Fiorentini C, Matarrese P, Straface E, Falzano L, Fabbri A, et al. (1998) Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp Cell Res 242: 341-350.
57. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A, (2003) Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725-742.
58. Malorni W, Fiorentini C, (2006) Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? Faseb J 20: 606-609.
59. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ, (2009) Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 4: e5517.
60. Vogelmann R, Amieva MR, (2007) The role of bacterial pathogens in cancer. Curr Opin Microbiol 10: 76-81.
61. Marchès O, Ledger TN, Boury M, Ohara M, Tu X, et al. (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Molecular Microbiology 50: 1553-1567 doi:10.1046/j.1365-2958.2003.03821.x.
62. Schauer DB, Zabel BA, Pedraza IF, O'Hara CM, Steigerwalt AG, et al. (1995) Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J Clin Microbiol 33: 2064-2068.
63. Barthold SW, Jonas AM, (1977) Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res 37: 4352-4360.
64. Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB, (2001) Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184: 227-230.
65. Bleday R, Braidt J, Ruoff K, Shellito PC, Ackroyd FW, (1993) Quantitative cultures of the mucosal-associated bacteria in the mechanically prepared colon and rectum. Dis Colon Rectum 36: 844-849.
66. Poxton IR, Brown R, Sawyerr A, Ferguson A, (1997) The mucosal anaerobic gram-negative bacteria of the human colon. Clin Infect Dis 25Suppl 2: S111-113.
67. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638 doi:10.1126/science.1110591.
68. Green GL, Brostoff J, Hudspith B, Michael M, Mylonaki M, et al. (2006) Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Microbiol 100: 460-469 doi:10.1111/j.1365-2672.2005.02783.x.
69. Gervaz P, Cerottini JP, Bouzourene H, Hahnloser D, Doan CL, et al. (2002) Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer. Surgery 131: 190-197.
70. Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventré A, et al. (2001) Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 147: 1671-1676.
71. Zhang L, Foxman B, Marrs C, (2002) Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol 40: 3951-3955.
72. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284-1289.
73. An Y, Jin G, Wang H, Wang Y, Liu H, et al. (2008) Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer 59: 164-170.
74. Hirata H, Hinoda Y, Kawamoto K, Kikuno N, Suehiro Y, et al. (2008) Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol 179: 2020-2024.
75. Koessler T, Oestergaard MZ, Song H, Tyrer J, Perkins B, et al. (2008) Common variants in mismatch repair genes and risk of colorectal cancer. Gut 57: 1097-1101.